Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-005459)

Filing Details

Accession Number:: 0001181431-11-005459
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-01-27 11:46:25
Reporting Period:: 2010-02-26

Filing Date:: 2011-01-27
Accepted Time:: 2011-01-27 11:46:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722104	Savient Pharmaceuticals Inc	SVNT	Medicinal Chemicals & Botanical Products (2833)	133033811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1456864	David Gionco	Savient Pharmaceuticals, Inc. One Tower Center, 14Th Floor East Brunswick NJ 08816	Group Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value Per Share	Acquisiton	2010-02-26	144	$11.45	44,563	No	4	A	Direct
Common Stock, $0.01 Par Value Per	Acquisiton	2010-05-31	71	$10.23	44,634	No	4	A	Direct
Common Stock, $0.01 Par Value Per	Acquisiton	2010-08-31	60	$11.95	44,694	No	4	A	Direct
Common Stock, $0.01 Par Value Per	Acquisiton	2010-11-30	73	$10.03	44,767	No	4	A	Direct
Common Stock, $0.01 Par Value Per	Disposition	2011-01-24	2,032	$10.00	42,735	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported on a Form 4.
These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on January 22, 2007.